Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 989.90
Change Today +35.20 / 3.69%
Volume 98.0
SLGN On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

solegreen ltd (SLGN) Snapshot

Open
$954.70
Previous Close
$954.70
Day High
$1,023
Day Low
$989.90
52 Week High
07/22/14 - $5,250
52 Week Low
05/18/15 - $880.00
Market Cap
31.6M
Average Volume 10 Days
2.9K
EPS TTM
$-4.63
Shares Outstanding
3.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SOLEGREEN LTD (SLGN)

Related News

No related news articles were found.

solegreen ltd (SLGN) Related Businessweek News

No Related Businessweek News Found

solegreen ltd (SLGN) Details

Solegreen Ltd. provides glycobiology and biopharmaceutical analytics services. The company develops GlycoScope for screening monoclonal antibody glycosylation profiles in the process of biopharmaceutical development and manufacturing, including cell line and clone selection, upstream and downstream process development, and manufacturing in-process control. It also offers glycosylation analysis services consisting of N-link and O-link glycans analysis; profiling and quantitative analysis of sialic acid; quantitative monosaccharide analysis; high throughput glycosylation analysis using GlycoScope; and consulting services. In addition, the company provides cytokine bioassays; diagnostic services comprising ELISA simple, western assays, and multiplex services; and other services, such as biosimilars analysis, Caco-2 permeability, cell labeling and tracking, and PEGylation. Further, it engages in the research and development of applications in the field of therapeutic stem cells using its Glycoscope technology platform. The company has collaboration with UniTargetingResearch AS for the development and commercialization of high-expression biosimilar and bio-better pharmaceuticals based on its proprietary UTR Tech technology platform. It primarily serves biopharmaceutical companies worldwide. The company was formerly known as Procognia (Israel) Ltd. and changed its name to Solegreen Ltd. in January 2015. Solegreen Ltd. was founded in 2000 and is based in Rehovot, Israel.

Founded in 2000

solegreen ltd (SLGN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

solegreen ltd (SLGN) Key Developments

Solegreen Ltd, Special/Extraordinary Shareholders Meeting, Jun 03, 2015

Solegreen Ltd, Special/Extraordinary Shareholders Meeting, Jun 03, 2015., at 11:00 Israel Standard Time.

ProCognia (Israel) Ltd, Special/Extraordinary Shareholders Meeting, Feb 04, 2015

ProCognia (Israel) Ltd, Special/Extraordinary Shareholders Meeting, Feb 04, 2015., at 11:00 Israel Standard Time.

ProCognia (Israel) Ltd, Annual General Meeting, Jan 12, 2015

ProCognia (Israel) Ltd, Annual General Meeting, Jan 12, 2015., at 11:00 Israel Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLGN:IT 989.90 +35.20

SLGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SLGN.
View Industry Companies
 

Industry Analysis

SLGN

Industry Average

Valuation SLGN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLEGREEN LTD, please visit www.procognia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.